Skip to content

Krystal Biotech, Inc. KRYS Other long-term liabilities

Other long-term liabilities at other companies

CACI International logo
CACI InternationalCACI
$869K+138%
Exxon Mobil logo
Exxon MobilXOM
-$357.5M+16.5%
Roblox logo
RobloxRBLX
$95M+69.2%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$79.23M+9.1%
Argan logo
ArganAGX
$13.33M+187%
Jacobs Solutions logo
Jacobs SolutionsJ
$196M+48.3%

Other financials

Income statement

See full
Revenue$116.4M+31.9%
Operating income$53.7M+48.1%
Net income$55.9M+56.5%
EPS (diluted)$1.83+52.5%

Balance sheet

See full
Cash & equivalents$501.3M+62.4%
Total debt$9.1M-5.7%
Total equity$1.3B+29.7%
Total assets$1.4B+30.0%

Cash flow

See full
Operating cash flow$80.4M+160%
CapEx$7.1M+15.2%
Free cash flow$73.2M+196%

Valuation

See full
Market cap$10.26B+45.4%
Enterprise value$9.77B+44.2%
P/E45.6×-11.3×
P/S24.6×+3.4×

Profitability

See full
Operating margin42.8%+10.2pp
Net margin53.9%+16.7pp
FCF margin56.9%+16.5pp

Returns & leverage

See full
Return on equity19.9%+6.0pp
Debt / equity0.0×
Current ratio9.5×-0.2×

Where this comes from

Reported directly by Krystal Biotech, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.

The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Krystal Biotech, Inc.'s other long-term liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Krystal Biotech, Inc.'s other long-term liabilities?
Krystal Biotech, Inc. (KRYS) reported other long-term liabilities of $1.44M in Q1 2026.
How has Krystal Biotech, Inc.'s other long-term liabilities changed year-over-year?
Krystal Biotech, Inc.'s other long-term liabilities increased by 168.7% year-over-year, from $534K to $1.44M.